February 6, 2017 / 9:02 AM / 8 months ago

BRIEF-Richter CEO sees 2017 revenues up 3 percent y/y

Feb 6 (Reuters) - Hungary’s Richter :

* Sees 2017 revenues from Esmya medicine at EUR 80 million -CEO

* Hungary’s Richter sees 2017 revenues from Grunenthal product portfolio at EUR 40-45 million - CEO

* Hungary’s Richter sees 2017 operating profit margin at 11 percent - CEO

* Hungary’s Richter sees 2017 revenues rising by 3 percent y/y in euros - CEO

* Sales and marketing expenses seen at 29-30 pct of 2017 revenues

* Research and development spending seen at 12 pct of revenues

* Gross margin seen at 56-57 pct -CEO

* Oral contraceptive market to contract over the long run

* CEO says 2017 guidance “not conservative, but realistic”

* Revenues from biggest market Russia to rise by 3 pct in roubles

* Polish, Romanian, domestic Hungarian revenues to stagnate in local currency terms Further company coverage: (Reporting by Marton Dunai)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below